UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2516-2522

2015

Volltextzugriff (PDF)

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Journal of clinical oncology, 2024-10

2024

Volltextzugriff (PDF)

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2013-05, Vol.31 (13), p.1631-1639

2013

Volltextzugriff (PDF)

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1358-1365

2010

Volltextzugriff (PDF)

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1585-1591

2009

Volltextzugriff (PDF)

Phase II Trial of Palliative Radiotherapy for Hepatocellular Carcinoma and Liver Metastases

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3980-3986

2013

Volltextzugriff (PDF)

Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic Malignancies

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8739-8747

2005

Volltextzugriff (PDF)

The use of stereotactic body radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.418-418

2016

Volltextzugriff (PDF)

Early stage hepatocellular carcinoma treated with stereotactic body radiation therapy: A pooled analysis from two North American institutions

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.350-350

2019

Volltextzugriff (PDF)

Stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.428-428

2019

Volltextzugriff (PDF)

Plasma and tumor genomic correlates of response to BYL719 in PI3KCA mutated metastatic ER-positive breast cancer (ER+/HER2- BC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1055-1055

2018

Volltextzugriff (PDF)

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Journal of clinical oncology, 2021-01, Vol.39 (1), p.66-78

2021

Volltextzugriff (PDF)

Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1044-1044

2017

Volltextzugriff (PDF)

The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “ indolent ” stage IV disease (Stage IV indolent )

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1019-1019

2018

Volltextzugriff (PDF)

Radiation Concurrent With Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study

Journal of clinical oncology, 2001-02, Vol.19 (3), p.792-799

2001

Volltextzugriff (PDF)

Is uterine serous carcinoma a part of hereditary breast cancer syndrome?

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5587-5587

2013

Volltextzugriff (PDF)

Patient recruitment in an oligometastases trial: experience from a phase II study of 5 fraction stereotactic body radiation therapy (SBRT)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14050-e14050

2016

Volltextzugriff (PDF)

Pembrolizumab (pembro) plus ipilimumab (ipi) or pegylated interferon alfa-2b (PEG-IFN) for advanced melanoma or renal cell carcinoma (RCC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3013-3013

2016

Volltextzugriff (PDF)

Pembrolizumab (pembro) plus low-dose ipilimumab (ipi) for patients (pts) with advanced renal cell carcinoma (RCC): Phase 1 KEYNOTE-029 study

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.510-510

2017

Volltextzugriff (PDF)

Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 U.S. patients (pts)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8550-8550

2014

Volltextzugriff (PDF)

Smoking status and treatment outcome in patients with pancreatic cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15676-e15676

2016

Volltextzugriff (PDF)

Outcomes following stereotactic body radiotherapy for patients with Child-Pugh B/C hepatocellular carcinoma

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.167-167

2013

Volltextzugriff (PDF)

Prospective evaluation of quality of life (QOL) during a phase I/II study of adjuvant chemotherapy with image-guided high-precision radiotherapy for completely resected gastric cancer

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.164-164

2016

Volltextzugriff (PDF)

Comparison of survival of African-American (AA) patients (pts) in docetaxel (D)-based combination therapies in metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.272-272

2016

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase II Trial of Palliative Radiotherapy for Hepatocellular Carcinoma and Liver Metastases

Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic Malignancies

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

The use of stereotactic body radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma

Early stage hepatocellular carcinoma treated with stereotactic body radiation therapy: A pooled analysis from two North American institutions

Stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion

Plasma and tumor genomic correlates of response to BYL719 in PI3KCA mutated metastatic ER-positive breast cancer (ER+/HER2- BC)

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study

The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “ indolent ” stage IV disease (Stage IV indolent )

Radiation Concurrent With Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study

Is uterine serous carcinoma a part of hereditary breast cancer syndrome?

Patient recruitment in an oligometastases trial: experience from a phase II study of 5 fraction stereotactic body radiation therapy (SBRT)

Pembrolizumab (pembro) plus ipilimumab (ipi) or pegylated interferon alfa-2b (PEG-IFN) for advanced melanoma or renal cell carcinoma (RCC)

Pembrolizumab (pembro) plus low-dose ipilimumab (ipi) for patients (pts) with advanced renal cell carcinoma (RCC): Phase 1 KEYNOTE-029 study

Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 U.S. patients (pts)

Smoking status and treatment outcome in patients with pancreatic cancer

Outcomes following stereotactic body radiotherapy for patients with Child-Pugh B/C hepatocellular carcinoma

Prospective evaluation of quality of life (QOL) during a phase I/II study of adjuvant chemotherapy with image-guided high-precision radiotherapy for completely resected gastric cancer

Comparison of survival of African-American (AA) patients (pts) in docetaxel (D)-based combination therapies in metastatic castrate-resistant prostate cancer (mCRPC)

Aktive Filter

Suchergebnisse filtern